|
| Press Releases |
|
 |
|
| Monday, April 4, 2022 |
|
|
EC Healthcare Opens New Multi-Service Flagship Medical Centre at Central and Advanced Imaging Centre at Taikoo |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong* more info >> |
|
| Wednesday, March 9, 2022 |
|
|
医思健康推出遥距医疗及药物配送服务 减少外出感染风险 守护市民健康 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，为减少市民外出就医风险，集团旗下的医思健康医疗中心、智健康、汇儿儿科医务中心及纽约医疗集团的脊医及中医服务均推出遥距视像诊症服务。 more info >> |
|
|
醫思健康推出遙距醫療及藥物配送服務 減少外出感染風險 守護市民健康 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，為減少市民外出就醫風險，集團旗下的醫思健康醫療中心、智健康、匯兒兒科醫務中心及紐約醫療集團的脊醫及中醫服務均推出遙距視像診症服務。 more info >> |
|
|
EC Healthcare Launch Tele-Medicine and Drug Delivery Service, Reduce Infection Risk and Protect Citizen's Health |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce, to reduce the infection risk from going out for medical consultation more info >> |
|
|
医思健康主席邓志辉进一步增持公司股份 对集团发展前景充满信心 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，于2022年3月7日，集团主席、行政总裁及执行董事邓志辉先生（「邓先生」）进一步于公开市场新增购入1,000,000股，涉资逾724.6万港元，每股股份平均价格约7.2465港元。 more info >> |
|
|
EC Healthcare's Chairman Eddy Tang Further Increases Shareholdings With Strong Confidence in the Group's Future Development |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Group's Chairman more info >> |
|
| Monday, March 7, 2022 |
|
|
医思健康获纳入深港通之合资格股份 |
| 香港最大非医院医疗服务机构* ── 医思健康（「公司」，连同附属公司，总称「集团」；香港联交所股份编号：2138）欣然宣布，根据深圳证券交易所于 2022年3月7日刊发的《关于深港通下的港股通股票名单调整的公告》，本公司为获纳入深港通的合资格股份，自 2022年3月7日起生效。 more info >> |
|
|
醫思健康獲納入深港通之合資格股份 |
| 香港最大非醫院醫療服務機構* ── 醫思健康（「公司」，連同附屬公司，總稱「集團」；香港聯交所股份編號：2138）欣然宣佈，根據深圳證券交易所於 2022年3月7日刊發的《關於深港通下的港股通股票名單調整的公告》，本公司為獲納入深港通的合資格股份，自 2022年3月7日起生效。 more info >> |
|
|
EC Healthcare Included as an Eligible Stock of the Shenzhen - Hong Kong Stock Connect |
| EC Healthcare (the "Company", which together with its subsidiaries is referred to as the "Group", SEHK stock code: 2138), the largest non-hospital medical group in Hong Kong*, is pleased to announce that the Company has been included as an eligible stock of Shenzhen-Hong Kong Stock Connect more info >> |
|
|
EC Healthcare and ClinicONE jointly launch A.I. Remote Nursing Program |
| EC Healthcare and ClinicONE jointly launched the intelligent remote health management platform Health.Me2 today. more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
Drilling at Congress Gold Mine Project Returns as high as 14.9 g/t Gold over 1.5m
Feb 1, 2023 23:00 HKT/SGT
|
|
|
Drilling at Congress Gold Mine Project Returns as high as 14.9 g/t Gold over 1.5m
Feb 1, 2023 23:00 HKT/SGT
|
|
|
ACROMETA Group Appoints Veteran Investor Mr. Levin Lee as Executive Chairman
Feb 1, 2023 16:00 HKT/SGT
|
|
|
Compact CO2 Capture System Receives "Awards for Excellence" at the 2022 Nikkei Excellent Products and Services Awards
Feb 1, 2023 16:52 JST
|
|
|
三菱重工、小型CO2回収装置が「2022年日経優秀製品・サービス賞」最優秀賞を受賞
Feb 1, 2023 15:20: JST
|
|
|
RHTLaw Asia strengthens Litigation & Dispute Resolution Practice through merger with ChangAroth Chambers
Feb 1, 2023 14:30 HKT/SGT
|
|
|
GenTwo Continues Growth Story, New Inflows of Over US$1 Billion
Feb 1, 2023 14:00 HKT/SGT
|
|
|
Society Pass (Nasdaq: SOPA) Engages ThinkEquity to Facilitate Stock Repurchase Program of Up to US$2 Million Commencing on 01 February 2023
Feb 1, 2023 14:00 HKT/SGT
|
|
|
Truescope Acquires US Firm Universal Information Services
Feb 1, 2023 12:30 HKT/SGT
|
|
|
マツダ、人事異動を発表
Feb 1, 2023 12:20: JST
|
|
|
Honda、小型耕うん機「サ・ラ・ダ FF300 20周年記念モデル」の受注開始
Feb 1, 2023 12:00: JST
|
|
|
富士通、世界最大のモバイル関連展示会「MWC Barcelona 2023」に出展
Feb 1, 2023 10:20: JST
|
|
|
欧康维视自研新药OT-101于中国完成完成受试者入组
Feb 1, 2023 10:02 HKT/SGT
|
|
|
歐康維視自研新藥OT-101於中國完成完成受試者入組
Feb 1, 2023 10:01 HKT/SGT
|
|
|
Ocumension Therapeutics Announces Its Patient Enrollment Completed In The Phase III Clinical Trail Of OT-101 In China
Feb 1, 2023 10:00 HKT/SGT
|
|
|
|
|
More News >> |
|
|
|
|
|
